NewcelX (NCEL) Cash & Equivalents (2019 - 2025)

NewcelX (NCEL) has reported Cash & Equivalents for 7 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Equivalents rose 238.62% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (up 238.62% YoY), while the FY2025 annual figure was $2.2 million, up 238.62% from the prior year.
• Cash & Equivalents improved to $2.2 million in Q4 2025 per NCEL's latest filing, from $299000.0 in the prior quarter.
• Across five years, Cash & Equivalents topped out at $7.1 million in Q2 2021 and bottomed at $299000.0 in Q2 2025.
• Historically, Cash & Equivalents has averaged $2.2 million across 5 years, with a median of $1.3 million in 2022.
• Annual changes were most pronounced in 2021 — Cash & Equivalents soared 5695.69% — and 2022, when it plunged 80.91%.
• NewcelX's Cash & Equivalents stood at $5.4 million in 2021, then tumbled by 66.56% to $1.8 million in 2022, then slumped by 36.89% to $1.1 million in 2023, then tumbled by 43.28% to $650000.0 in 2024, then surged by 238.62% to $2.2 million in 2025.
• Business Quant data shows NCEL's Cash & Equivalents at $2.2 million in Q4 2025, $299000.0 in Q2 2025, and $650000.0 in Q4 2024.